Navigation Links
E7: The Outlook for Pharmaceuticals to 2012
Date:1/11/2012

a collaboration focused on the research, development and commercialisation of innovative drugs in Russia; and the launching of Pro Bono Bio as a new international pharmaceutical company as a result of a three-year Anglo/Russian project.

TURKEY

There have been a number of recent acquisitions by foreign pharmaceutical companies. In September 2011, Italy's Recordati successfully concluded its acquisition of Dr F Frik Ilac, headquartered in Istanbul. This was Recordati's second acquisition in Turkey, following the acquisition of Yeni Ilac in 2008. In September 2011, USA's Eli Lilly began talks to invest in and form a partnership with Mustafa Nevzat (MN) Pharmaceuticals; it is also possible MN could sell a stake to a Middle Eastern sovereign wealth fund. In May 2011, Poland's Polpharma acquired a majority of shares in Cenovapharma. In April 2011, Nycomed entered into several agreements with various local pharmaceutical companies to replace Biomeks Ilac as the marketing authorisation holder and distributor for the majority of the company's product portfolio in Turkey. Local companies are strengthening their position in the local market by expanding manufacturing capabilities.

THESE REPORTS ANALYSE THE ISSUES The E7: The Outlook for Pharmaceuticals is a unique collection of management reports from Espicom Business Intelligence. Each report provides individual and highly-detailed analysis of each market, looking at the key regulatory, political, economic and corporate developments in the wider context of market structure, service and access. The reports are available individually, or as a discounted collection, and prices include 4 completely updated reports sent quarterly, together with a comprehensive statistical appendix. There are over 60 markets covered in the worldwide series.To order this report:Pharma
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Hill-Rom Announces Preliminary Fiscal First Quarter Financial Results; Updates 2012 Financial Outlook
2. The Outlook for Medical Devices Worldwide
3. Magnetic Resonance Imaging (MRI) Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
4. The Outlook for Pharmaceuticals Worldwide
5. Unigene Provides 2012 Business Outlook
6. ViroPharma Provides 2012 Outlook
7. Zacks Industry Outlook Highlights: Vertex Pharma, Human Genome Sciences, Biogen Idec and Perrigo
8. Anesthesia Machines in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
9. South and Central America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
10. Brazil Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others
11. Asia-Pacific Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... N.C. , Aug. 28, 2015  Delays ... research projects can slow down the decision-making process, ... is, therefore, absolutely critical for biopharmaceutical companies to ... research approval process for quicker and more meaningful ... by Best Practices, LLC, nearly three-quarters of benchmarked ...
(Date:8/28/2015)... 2015 Research and ... of the "Investigation Report on China,s Pranoprofen ... Originally discovered by Welfide (Mitsubishi Tanabe Pharma ... as an inflammatory drug, pranoprofen was later developed ... under the trade name of pranopulin for the ...
(Date:8/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/jq34zf/investigation ) ... on China,s Tobramycin Market, 2010-2019" report to their ... eye drop and ointment are the most common prescription ... caused by eye infection. Currently, dozens of enterprises in ... tobramycin, among which the Top 5 are s.a. Alcon- ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 2Investigation Report on China's Pranoprofen Market, 2010-2019 2Investigation Report on China's Tobramycin Market, 2015-2019 2
... Champions Oncology, Inc.  ("Champions" or  the ... a company engaged in the development of advanced technology ... of oncology drugs, has appointed Gary G. Gemignani to ... Chief Financial Officer. Joel Ackerman, the Company,s Chief Executive ...
... When it comes to breast cancer, a physician,s ability to ... treatment depends on the quality of information revealed through diagnostic ... most advanced technology in breast cancer detection with positron emission ... scanners in the Chicagoland area. Essentially, PEM is ...
Cached Medicine Technology:Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation 2Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation 3Palos Offers New Technology in the Fight Against Breast Cancer 2
(Date:8/30/2015)... , ... August 30, 2015 , ... ... has been promoted from Administrative assistant to Executive Assistant to CEO Mitch Gould ... a proven professional, focused on your goals. Kathleen graduated from Florida State ...
(Date:8/29/2015)... ... August 30, 2015 , ... Rio Salado College President Chris ... college’s Vice President of Strategic Initiatives and Information Services. O’Shea, who has served Rio ... expand its reach and impact through innovative technologies and strategies. , “I am very ...
(Date:8/29/2015)... Church, VA (PRWEB) , ... August 30, 2015 ... ... **FDAnews Webinar**, Sept. 15, 2015 — 1:30 p.m. – 3:00 p.m. EDT, ... much more than a simple digital handwritten signature. , Clinical trial ...
(Date:8/29/2015)... PITTSBURGH, PA (PRWEB) , ... August 29, 2015 ... ... 1996," said one of two inventors from Miller Place, N.Y. "I specialize in ... pain and discomfort. In addition, it can be used for additional muscle dysfunction ...
(Date:8/29/2015)... ... August 29, 2015 , ... Targeted therapies, ... improve the lives of patients, according to a newly published report. Surviving Mesothelioma ... the full article. , The authors of the new paper focus on ...
Breaking Medicine News(10 mins):Health News:NPI Appoints New Executive Assistant To CEO 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 2Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 3Health News:FDAnews Announces — Electronic Informed Consent for Clinical Trials: Best Practices Webinar, Sept. 15, 2015 4Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2
... Hospitalar LFE 250SX and LFE 200SX to Target ... Bioscience (Nasdaq: PURE ) today announced ... (Lifebio), recently obtained national regulatory approval for its ... LFE 200SX" and "Desinfetante Hospitalar LFE 250SX," which ...
... City-Based Site Pulls Together Extensive State/Local Resources and ... A breakthrough Web solution for families, consumers and ... is now available to all New Yorkers. ... Behavioral Health ( www.nycnetworkofcare.org ) is an online ...
... Alta Bates Summit Medical Center will offer a free skin ... Street, Oakland, CA, 94609. This community cancer screening is supported ... Bay Area non-profit dedicated to changing the face of cancer. ... being diagnosed each year, skin cancer is the most common ...
... Service Corporation (Nasdaq: PRSC ) today announced ... million annual contract to operate a consumer-run adult mental ... contract is being funded through the state,s Mental Health ... home and community based delivery model is very much ...
... Choose Different Approaches, Yet Face Hurdles in Light ... HealthLeaders-InterStudy NASHVILLE, Tenn., Feb. 19 HealthLeaders-InterStudy, ... reports that significant state Medicaid reform efforts in ... in light of the nation,s economic downturn, particularly ...
... 19 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI ; ... results for the fourth quarter ending December 31, 2008 and ... 2009. Unless specified otherwise, all amounts are in U.S. dollars ... pivotal year for us as we concluded a series of ...
Cached Medicine News:Health News:PURE Bioscience Announces Brazilian Regulatory Approval for SDC-Based Hospital-Grade Disinfectants 2Health News:PURE Bioscience Announces Brazilian Regulatory Approval for SDC-Based Hospital-Grade Disinfectants 3Health News:PURE Bioscience Announces Brazilian Regulatory Approval for SDC-Based Hospital-Grade Disinfectants 4Health News:NAMI-NYC Metro Gives New Yorkers the Most Comprehensive Mental Health Web Site in Effort to Help Transform Care 2Health News:NAMI-NYC Metro Gives New Yorkers the Most Comprehensive Mental Health Web Site in Effort to Help Transform Care 3Health News:Lazarex Cancer Foundation Sponsors Free Community Skin Cancer Screening at Alta Bates Summit Medical Center 2Health News:Providence Service Corporation California Subsidiary Awarded $1.5 Million Contract Under State's Mental Health Services Act 2Health News:Medicaid Reform Efforts Underway in Louisiana and Rhode Island 2Health News:Medicaid Reform Efforts Underway in Louisiana and Rhode Island 3Health News:QLT Announces Fourth Quarter and Year End 2008 Results 2Health News:QLT Announces Fourth Quarter and Year End 2008 Results 3Health News:QLT Announces Fourth Quarter and Year End 2008 Results 4Health News:QLT Announces Fourth Quarter and Year End 2008 Results 5Health News:QLT Announces Fourth Quarter and Year End 2008 Results 6Health News:QLT Announces Fourth Quarter and Year End 2008 Results 7Health News:QLT Announces Fourth Quarter and Year End 2008 Results 8Health News:QLT Announces Fourth Quarter and Year End 2008 Results 9Health News:QLT Announces Fourth Quarter and Year End 2008 Results 10Health News:QLT Announces Fourth Quarter and Year End 2008 Results 11Health News:QLT Announces Fourth Quarter and Year End 2008 Results 12Health News:QLT Announces Fourth Quarter and Year End 2008 Results 13Health News:QLT Announces Fourth Quarter and Year End 2008 Results 14Health News:QLT Announces Fourth Quarter and Year End 2008 Results 15Health News:QLT Announces Fourth Quarter and Year End 2008 Results 16Health News:QLT Announces Fourth Quarter and Year End 2008 Results 17Health News:QLT Announces Fourth Quarter and Year End 2008 Results 18Health News:QLT Announces Fourth Quarter and Year End 2008 Results 19
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: